Evidence map›Paper›PMID 29091132›Full record

ReviewMemorias do Instituto Oswaldo Cruz2017

Cytotoxic activity in cutaneous leishmaniasis.

Taís M Campos, Rúbia Costa, Sara Passos, Lucas P Carvalho

Open access · diamondAbstract readReview
In one paragraph

Review in Memorias do Instituto Oswaldo Cruz, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Development of an immunogen containing CD4Applied microbiology and biotechnology · 2022
    Article
  9. Protection and Pathology inPathogens (Basel, Switzerland) · 2022
    Review
  10. Article
  11. Viruses · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Taís M CamposUniversidade Federal da Bahia, Serviço de Imunologia, Salvador, BA, Brasil.
Rúbia CostaUniversidade Federal da Bahia, Serviço de Imunologia, Salvador, BA, Brasil.
Sara PassosUniversidade Federal da Bahia, Serviço de Imunologia, Salvador, BA, Brasil.
Lucas P CarvalhoUniversidade Federal da Bahia, Serviço de Imunologia, Salvador, BA, Brasil.
Universidade Federal da Bahia · BRHouston Methodist · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous leishmaniasis (CL) is a chronic disease caused by species of the protozoan Leishmania and characterised by the presence of ulcerated skin lesions. Both parasite and host factors affect the clinical presentation of the disease. The development of skin ulcers in CL is associated with an inflammatory response mediated by cells that control parasite growth but also contribute to pathogenesis. CD8+ T cells contribute to deleterious inflammatory responses in patients with CL through cytotoxic mechanisms. In addition, natural killer cells also limit Leishmania infections by production of interferon-γ and cytotoxicity. In this review, we focus on studies of cytotoxicity in CL and its contribution to the pathogenesis of this disease.

Indexed as

AnimalsCD8-Positive T-LymphocytesCytotoxicity, ImmunologicDisease Models, AnimalHumansKiller Cells, NaturalLeishmaniasis, CutaneousT-Lymphocytes, Cytotoxic

Identifiers

PMID29091132
PMCPMC5661895
OpenAlexW2767169933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.